Avianca Cargo has become the first airline in the Americas to earn Good Distribution Practice (GDP) certification for pharmaceutical transport, a credential that signals the Colombian carrier's push into one of air cargo's highest-yielding and most demanding freight segments.

The certification, awarded under GDP standards for pharmaceutical logistics, places Avianca Cargo ahead of every other carrier operating in North, Central and South America. Until now, no airline in the region had cleared the audit benchmark that European and Middle Eastern pharma-focused operators have used to position themselves in temperature-sensitive freight.

For the airline, the commercial logic is straightforward. Pharmaceutical cargo commands premium rates compared with general freight because shippers require validated cold chains, documented handling procedures and audited facilities at every touchpoint. Carriers that cannot demonstrate GDP compliance are effectively locked out of tenders from major pharmaceutical manufacturers and their logistics providers, who increasingly screen for the certification as a precondition.

The first-mover position matters for forwarders and shippers moving pharma through the Americas. Avianca Cargo's network centres on Latin America, a region where pharmaceutical imports and exports have grown steadily and where validated cold-chain capacity has historically been thin relative to demand. A GDP-certified carrier based in the region gives forwarders an alternative to routing temperature-sensitive shipments through European or Gulf hubs to reach a certified operator.

The certification also reframes the competitive picture for Avianca Cargo itself. The carrier, which operates a freighter fleet serving the Americas and Europe, has been rebuilding its cargo business in the aftermath of the industry's pandemic-era boom and the subsequent rate correction. Pharma tonnage, with its rate premium and lower volatility than e-driven general cargo, offers a hedge against the freight-rate cycles that have battered carrier yields since 2022.

For competitors, the development sets a benchmark. Other carriers in the region will now face shipper expectations calibrated against a certified operator, and the audit trail that GDP compliance demands — covering facility design, temperature monitoring, staff training and deviation management — takes time and capital to build. Avianca Cargo's head start may hold for several quarters before rivals close the gap.

Shippers gain a direct benefit beyond carrier choice. GDP certification requires documented, auditable handling from acceptance to delivery, which reduces the loss and spoilage risk that drives insurance costs and quality disputes in pharma logistics. For manufacturers shipping into Latin American markets, where last-mile temperature excursions remain a persistent problem, a certified airline segment of the chain tightens control over the leg carriers actually manage.

The move tracks a broader industry pattern. Airlines and ground handlers worldwide have pursued pharmaceutical certifications — most prominently through programmes modelled on GDP and the industry's handling standards — as pharma air freight has become a structural growth market, anchored in vaccine distribution, biologic medicines and regional healthcare supply chains that COVID-19 exposed as fragile.

Avianca Cargo will now look to convert the certification into contracted tonnage. The credential opens doors to pharma tenders, but the revenue depends on maintaining the audit standards in daily operations and convincing forwarders that the Americas-based network can deliver consistency on par with certified European operators.

The certification signals where regional air cargo competition is heading: away from capacity alone and toward verified handling quality in high-value verticals. Expect other carriers in the Americas to pursue GDP compliance in the coming quarters as pharmaceutical shippers formalise certified-carrier requirements in their procurement.